Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Discoveries (Craiova, Romania)|April 21, 2020
Simple Chemoinformatics Criterion Using Electron Donor-Acceptor Molecular Characteristics for Selection of Antibiotics Against Multi-Drug-Resistant BacteriaVeljko Veljkovic, Sanja Glisic, Vladimir Perovic, et al.
BMC Structural Biology|September 30, 2009
Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptorVeljko Veljkovic, Henry L Niman, Sanja Glisic, et al.
Frontiers in Bioscience (Landmark Edition)|September 21, 2017
Ibuprofen as a template molecule for drug design against Ebola virusSlobodan Paessler, Cheng Huang, Milan Sencanski, et al.
Molecular Informatics|February 21, 2020
Deciphering Imidazoline Off-targets by Fishing in the Class A of GPCR fieldTeodora Djikic, Jelica Vucicevic, Jonne Laurila, et al.
Current Pharmaceutical Design|October 3, 2015
Natural Products as Promising Therapeutics for Treatment of Influenza DiseaseMilan Sencanski, Draginja Radosevic, Vladimir Perovic, et al.
BMC Structural Biology|April 9, 2009
Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection controlVeljko Veljkovic, Nevena Veljkovic, Claude P Muller, et al.
Plos One|November 10, 2016
Predicted Enhanced Human Propensity of Current Avian-Like H1N1 Swine Influenza Virus from ChinaVeljko Veljkovic, Nevena Veljkovic, Slobodan Paessler, et al.
Frontiers in Microbiology|January 7, 2016
Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New PandemicVeljko Veljkovic, Slobodan Paessler, Sanja Glisic, et al.
Scientific Reports|November 14, 2019
Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β2-adrenergic receptor (β2-AR)Milan Sencanski, Sanja Glisic, Marko Šnajder, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 25, 2015
Rilmenidine suppresses proliferation and promotes apoptosis via the mitochondrial pathway in human leukemic K562 cellsTatjana Srdic-Rajic, Katarina Nikolic, Milena Cavic, et al.
Pageof 6